Algert Global LLC Acrivon Therapeutics, Inc. Transaction History

Algert Global LLC

$5.98 Billion
Q3 2025

A detailed history of Algert Global LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 44,648 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,648

Holding current value

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 14, 2025	BUY	N/A	44,648 New	44,648 $81,000

Others Institutions Holding ACRV

# of Institutions

Shares Held

18.2M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

8.34M
Shares

$0
0.0% of portfolio
Sands Capital Ventures, LLC Arlington, VA

2.12M
Shares

$0
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

1.54M
Shares

$0
0.0% of portfolio
Wellington Management Group LLP Boston, MA

888K
Shares

$0
0.0% of portfolio
Black Rock Inc. New York, NY

767K
Shares

$0
0.0% of portfolio

View Full List

About Acrivon Therapeutics, Inc.

Ticker ACRV

More about ACRV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account